Post Surgical Neuropathic Pain clinical trials at University of California Health
1 in progress, 0 open to eligible people
Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery
Sorry, not currently recruiting here
This is an interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated topical application of Qutenza (capsaicin 8% topical system) versus low-dose capsaicin control (capsaicin 0.04% topical system) in subjects with moderate to severe postsurgical neuropathic pain (PSNP).
Our lead scientists for Post Surgical Neuropathic Pain research studies include Mark Wallace.